Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
292 studies found for:    Open Studies | "Pharyngeal Diseases"
Show Display Options
Rank Status Study
1 Recruiting The Lolland-Falster Health Study
Conditions: Impaired Health;   Disease;   Wellbeing;   Mental Disorders;   Atherosclerosis;   Renal Insufficiency, Chronic;   Skin Diseases;   Urinary Incontinence;   Personality;   Coronary Disease;   Ear Diseases;   Nose Diseases;   Pharyngeal Diseases;   Chronic Disease
2 Recruiting TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Other: Drug: Taxol,cisplatin and capecitabine;   Other: Drug: Cisplatin and 5-Fluorouracil
3 Recruiting Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer
Condition: Esophageal Neoplasms [C06.405.117.430]
Interventions: Device: Chrono-chemotherapy pump:Melodie;   Device: Routine intravenous drip;   Drug: induction Chrono-chemotherapy;   Drug: induction Routine-chemotherapy;   Drug: cisplatin chrono-chemotherapy;   Drug: cisplatin routine-chemotherapy;   Radiation: intensity-modulated radiation therapy
4 Not yet recruiting Impact of HPV Vaccine On The Prevalence Of HPV In Norway
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer;   Oropharyngeal Cancer
Interventions: Procedure: Self sample from vagina;   Procedure: Self sample from the oral cavity;   Other: Questionnaire
5 Recruiting Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
Conditions: Parkinson's Disease;   Dysphagia;   Dystussia
Interventions: Device: EMST;   Behavioral: smTAP
6 Not yet recruiting Computerized Acoustic Swallowing Evaluation
Conditions: Deglutition Disorders;   Stroke
Intervention: Other: Swallowing Screen
7 Not yet recruiting ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
Conditions: Oral Cavity Neoplasm;   Oropharyngeal Neoplasm;   Stage I Oral Cavity Squamous Cell Carcinoma;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oral Cavity Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Oral Cavity Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet;   Other: Pharmacological Study;   Other: Placebo
8 Recruiting EpCAM CAR-T for Treatment of Nasopharyngeal Carcinoma and Breast Cancer
Conditions: Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M);   Breast Cancer Recurrent
Intervention: Biological: CAR-T cells recognizing EpCAM
9 Not yet recruiting The Study to Evaluate JS001 in Patients With Advanced GC, ESCC, NPC, HNSCC
Conditions: Gastric Adenocarcinoma;   Esophageal Squamous Cell Carcinoma;   Nasopharyngeal Carcinoma;   Head and Neck Squamous Cell Carcinoma
Interventions: Biological: 3 mg/kg humanized anti-PD-1 mAb;   Biological: 10 mg/kg humanized anti-PD-1 mAb
10 Recruiting Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer
Condition: Oropharynx Cancer
Interventions: Radiation: Adjuvant Radiation Therapy;   Drug: Docetaxel;   Drug: Cisplatin
11 Not yet recruiting Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Endostar;   Drug: DDP
12 Recruiting A Trial of Endostar in Patients With Carcinoma of the Head and Neck
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Endostar
13 Recruiting A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.
Condition: Nasopharyngeal Carcinoma.
Intervention: Drug: S-1
14 Recruiting Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Intervention: Drug: Avelumab
15 Not yet recruiting ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Apatinib;   Drug: Placebo
16 Not yet recruiting Incidence of Dysphagia in Intensive Care Patients With Tracheostomy
Conditions: Dysphagia;   Oropharyngeal Dysphagia
Intervention: Device: high resolution impedance manometry with Automated Impedance Manometry analysis
17 Not yet recruiting Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Cisplatin combine with IMRT
18 Recruiting Improving the Diagnosis of Tonsillitis in Emergency Rooms
Condition: Tonsillitis
Intervention: Other: Nasopharyngeal swab
19 Recruiting E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers
Conditions: Cervical Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions: Biological: E7 TCR cells;   Drug: pembrolizumab;   Drug: aldesleukin;   Drug: fludarabine;   Drug: cyclophosphamide
20 Not yet recruiting Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients
Condition: Nasopharyngeal Carcinoma
Interventions: Dietary Supplement: Sodium nitrate;   Dietary Supplement: sodium chloride

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years